Abstract:Aim: To observe the biocompatibility of β-tricalcium phosphate (TCP)/calcium polyphosphate fiber (CPPF)/poly-levolactic acid (PLLA) composite as a novel bone tissue engineered scaffold by observing the morphology and proliferation of in vitro cultured cells. Methods: The experiment was carried out in the experimental center of Medical College and Institute of Endemic Diseases, Xi'an Jiaotong University from January 2002 to January 2004. 1 β-TCP/CPPF/PLLA scaffold was prepared by the Institute of Composite Materials, Lanzhou Jiaotong University; CPPF was (15.0±1.2) μm in diameter with (3.0± 0.46)% mean biodegradation rate, (1.0±0.2) GPa tensile strength, and (48.0±7.6) GPa; the mean molecular mass of PLLA was 27.6×104. The weight ratio of scaffold composite was β-TCP:CPPF:PLLA=2:3:5. 2 With the proportion of 1 g composite:10 mL extraction mediator, β-TCP/CPPF/PLLA scaffold was extracted by using DMEM containing 0.1 volume fracture fetal bovine serum at 37°C for 24 to 72 hours to prepare the extraction fluid, which was filtered before using. The bone marrow stromal cells (BMSCs) were divided into 3 groups and cultured with β-TCP/CPPF/PLLA maceration extract (experiment group), DMEM culture medium (negative control group) and 6.4 g/L Phenol solutions (positive control group), and the dilution of the maceration extract was divided into 100%, 75%, 50%, and 25%, respectively. 3 The growth and change condition of BMSCs were observed by phase contrast microscope. The growth and proliferation of BMSCs were investigated with MTT method to determine A value and calculate the proliferation rate of cells. Results: 1 On days 1, 2 and 3, the cell number of the positive control group displayed noticeable decrease, and the cells were of pyknosis even disaggregation; the cell number of the experiment group and negative control group was remarkably increased with normal call appearance. 2 At each time point of culture, the cytotoxicity of all groups were grade 0 with more than 80% cell proliferation rate except the positive control group was grade 4 with 0-20% cell proliferation rate; except the positive control group, the A values of experiment groups and negative control group were increased with culture days, and the A value of the positive control group on days 1, 2 and 3 was much lower than other groups (P < 0.01);. there were no significant differences between negative control group and experiment group (P > 0.05). Conclusion: β-TCP/CPPF/PLLA scaffold composite has a negligible influence and differentiation of BMSCs. It has good cell compatibility and no cytotoxicity.

Enhancing osteogenic differentiation of MC3T3-E1 cells during inflammation using UPPE/β-TCP/TTC composites via the Wnt/β-catenin pathway.

Enhancing Osteogenic Differentiation of MC3T3-E1 Cells During Inflammation Using UPPE/β-TCP/TTC Composites Via the Wnt/β-catenin Pathway

Enhancing osteogenic differentiation of MC3T3-E1 cells during inflammation using UPPE/β-TCP/TTC composites <i>via</i> the Wnt/β-catenin pathway (vol 14, pg 3761, 2024)

Preparation, characterization, cellular response and in vivo osseointegration of polyetheretherketone/nano-hydroxyapatite/carbon fiber ternary biocomposite

In vitro cytotoxicity of a novel injectable and biodegradable alveolar bone substitute.

Development of Nanophase β-Tricalcium Phosphate/Collagen Fiber Composites for Improving Cell Adhesion and Proliferation

Degradability and cytocompatibility of tricalcium phosphate/poly(amino acid) composite as bone tissue implants in orthopaedic surgery.

A Carboxymethyl Chitosan and Peptide-Decorated Polyetheretherketone Ternary Biocomposite with Enhanced Antibacterial Activity and Osseointegration As Orthopedic/dental Implants

Microencapsulated MC3T3 E1 Cells/Calcium Phosphate Cement for Bone Formation in Vivo

Implantable PEKK/tantalum Microparticles Composite with Improved Surface Performances for Regulating Cell Behaviors, Promoting Bone Formation and Osseointegration.

A preliminary trial of the novel injectable alvelor bone substitutes for tetracycline controlled delivery to periodontal pockets in dogs

[Effects of Sintered Bone Modified with Surface Mineralization/p24 Peptide Composite Biomaterial on the Adhesion, Proliferation and Osteodifferentiation of MC3T3-E1 Cells].

Tuning of the Surface Biological Behavior of Poly(l-Lactide)-based Composites by the Incorporation of Polyelectrolyte Complexes for Bone Regeneration

Evaluation of polyetheretherketone composites modified by calcium silicate and carbon nanotubes for bone regeneration: mechanical properties, biomineralization and induction of osteoblasts

Porous BCP Ceramics with Nanoscale Whisker Structure Accelerate Bone Regeneration by Regulating Inflammatory Response.

Effects of silicate-based composite material on the proliferation and mineralization behaviors of human dental pulp cells: An in vitro assessment

Cell biocompatibility of beta-tricalcium phosphate/calcium polyphosphate fiber/polylevolactic acid composite as a novel bone tissue-engineered scaffold

Effect of an Experimental Direct Pulp-capping Material on the Properties and Osteogenic Differentiation of Human Dental Pulp Stem Cells

Influence of a novel injectable alvelor bone substitutes on regeneration of periodontal defects with experimen- tal periodontitis in dogs

Cytocompatibility of the nanophase beta-tricalcium phosphate /collagen fibers composite

The Enhancement of Bone Regeneration by a Combination of Osteoconductivity and Osteostimulation Using Β-Casio3/β-ca3(po4)2 Composite Bioceramics.